About Metabolic Dysfunction-Associated Steatohepatitis (MASH) MASH is a chronic, progressive metabolic disease affecting the liver, which can be potentially life-threatening if not properly managed
Those who were prescribed the drug often found that it not only helped to control their diabetes better, but they also experienced weight loss
Summary of Benefits Fast eligibility quiz and onboarding No insurance required Transparent, flat-rate pricing Nationwide medication delivery Licensed clinical oversight and unlimited messaging Access to both compounded and name-brand GLP-1 medications These features make FuturHealth one of the most accessible and consumer-friendly options in the telehealth weight loss space
Researchers tracking the dual-agonist story often follow the triple-agonist literature next
Comprehensive Weight Management Approach Effective weight loss requires more than medication alone
Periods of exclusivity for pharmaceutical products end as part of their normal life cycle, and generic treatments may become available over time. The company confirmed that protection for semaglutide regulatory submissions in Canada will expire in 2026
